[HTML][HTML] Long-term safety and efficacy of factor IX gene therapy in hemophilia B

AC Nathwani, UM Reiss… - … England Journal of …, 2014 - Mass Medical Soc
Background In patients with severe hemophilia B, gene therapy that is mediated by a novel
self-complementary adeno-associated virus serotype 8 (AAV8) vector has been shown to …

Age-related macular degeneration

T Ayoub, N Patel - Journal of the Royal Society of Medicine, 2009 - journals.sagepub.com
Age-related macular degeneration (AMD) is the leading cause of blindness and visual
disability in patients aged over 60 years in Europe and North America. 1 It is the third …

Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy

C Toomes, NJ Marchbank, DA Mackey… - Human molecular …, 2001 - academic.oup.com
Dominant optic atrophy (DOA) is the commonest form of inherited optic neuropathy.
Although heterogeneous, a major locus has been mapped to chromosome 3q28 and the …

Targeting leukostasis for the treatment of early diabetic retinopathy

N Patel - … & Haematological Disorders-Drug Targets (Formerly …, 2009 - ingentaconnect.com
Leukocyte-endothelial interaction plays an important role in the early phase of the
development of diabetic retinopathy. It has been studied extensively linking inflammatory …

Circulating anti‐retinal antibodies as immune markers in age‐related macular degeneration

N Patel, M Ohbayashi, AK Nugent, K Ramchand… - …, 2005 - Wiley Online Library
Age‐related macular maculopathy (ARM) and age‐related macular degeneration (AMD) are
the leading causes of blindness in the Western world. Despite the magnitude of this clinical …

First-year visual acuity outcomes of providing aflibercept according to the VIEW study protocol for age-related macular degeneration

JS Talks, AJ Lotery, F Ghanchi, S Sivaprasad… - Ophthalmology, 2016 - Elsevier
Purpose Aflibercept has the potential advantage of reducing capacity problems by allowing
2 monthly visits for patients with neovascular macular degeneration (nAMD) compared with …

Uro-symphyseal Fistula: A Systematic Review to inform a contemporary, evidence-based management framework

N Patel, G Mehawed, N Dunglison, R Esler… - Urology, 2023 - Elsevier
Objectives To collate available data via systematic review considering aetiology,
presentation and treatment of Uro-Symphyseal Fistula (USF) in order to inform a …

Identification of anti-retinal antibodies in patients with age-related macular degeneration

K Morohoshi, M Ohbayashi, N Patel, V Chong… - … and molecular pathology, 2012 - Elsevier
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
industrial counties. Recent findings indicate that the autoimmunity is involved in the …

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization

K Morohoshi, N Patel, M Ohbayashi, V Chong… - … and molecular pathology, 2012 - Elsevier
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in
industrial counties. Its pathogenesis is at least partially mediated by immunological factors …

[HTML][HTML] FGF signalling regulates chromatin organisation during neural differentiation via mechanisms that can be uncoupled from transcription

NS Patel, M Rhinn, CI Semprich, PA Halley… - PLoS …, 2013 - journals.plos.org
Changes in higher order chromatin organisation have been linked to transcriptional
regulation; however, little is known about how such organisation alters during embryonic …